29 related articles for article (PubMed ID: 15740593)
1. Cooperation of TGF-β and FGF signalling pathways in skin development.
Li X; Xie R; Luo Y; Shi R; Ling Y; Zhao X; Xu X; Chu W; Wang X
Cell Prolif; 2023 Nov; 56(11):e13489. PubMed ID: 37150846
[TBL] [Abstract][Full Text] [Related]
2. The glycan-binding protein galectin-9 has direct apoptotic activity toward melanoma cells.
Wiersma VR; de Bruyn M; van Ginkel RJ; Sigar E; Hirashima M; Niki T; Nishi N; Samplonius DF; Helfrich W; Bremer E
J Invest Dermatol; 2012 Sep; 132(9):2302-5. PubMed ID: 22572821
[No Abstract] [Full Text] [Related]
3. Melanoma: from mutations to medicine.
Tsao H; Chin L; Garraway LA; Fisher DE
Genes Dev; 2012 Jun; 26(11):1131-55. PubMed ID: 22661227
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta1 induces apoptosis in normal melanocytes but not in nevus cells grown in type I collagen gel.
Alanko T; Saksela O
J Invest Dermatol; 2000 Aug; 115(2):286-91. PubMed ID: 10951248
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
6. FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes.
Alanko T; Rosenberg M; Saksela O
J Invest Dermatol; 1999 Jul; 113(1):111-6. PubMed ID: 10417628
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-2 maintains the differentiation potential of nucleus pulposus cells in vitro: implications for cell-based transplantation therapy.
Tsai TT; Guttapalli A; Oguz E; Chen LH; Vaccaro AR; Albert TJ; Shapiro IM; Risbud MV
Spine (Phila Pa 1976); 2007 Mar; 32(5):495-502. PubMed ID: 17334282
[TBL] [Abstract][Full Text] [Related]
9. FGF-2 blocks TGF-beta1-mediated suppression of Bcl-2 in normal melanocytes.
von Willebrand M; Köhler K; Alanko T; Laiho M; Saksela O
Exp Dermatol; 2005 Mar; 14(3):202-8. PubMed ID: 15740593
[TBL] [Abstract][Full Text] [Related]
10. Dual role for TGF-beta1 in apoptosis.
Sánchez-Capelo A
Cytokine Growth Factor Rev; 2005 Feb; 16(1):15-34. PubMed ID: 15733830
[TBL] [Abstract][Full Text] [Related]
11. Biology of tumor progression in human melanocytes.
Herlyn M; Clark WH; Rodeck U; Mancianti ML; Jambrosic J; Koprowski H
Lab Invest; 1987 May; 56(5):461-74. PubMed ID: 3553733
[TBL] [Abstract][Full Text] [Related]
12. Growth control of melanoma cells and melanocytes by cytokines.
Krasagakis K; Garbe C; Zouboulis CC; Orfanos CE
Recent Results Cancer Res; 1995; 139():169-82. PubMed ID: 7597288
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
